【New York General Group】Success in having artificial intelligence perform atomic/molecular simulations to develop new drugs
New York General Group has the world's most advanced science and technology, QTIS (Quantum Theory Informed Superintelligence).
This technology can be applied to a variety of industries, one of which is the pharmaceutical industry. In this case, New York General Group's algorithms have successfully allowed artificial intelligence to develop a new drug from scratch.
【Excerpt from the results of ordering QTIS to develop a new drug. QTIS has developed an entirely new chronic pain relief drug called "QuantumRelief."】
【Result of a similar instruction to a large language model (ChatGPT). Only general descriptions of atomic/molecular simulations and drug discovery were available.】
【QTIS-generated "QuantumRelief" package insert.】
The important point is that it took less than a minute from human instruction to the development of the drug by artificial intelligence. Our artificial intelligence also understands the spatial structure and temporal motion of atoms/molecules based on quantum mechanics, which enables highly accurate drug discovery.
The following is the original paper of the science and technology (QTIS).
We are currently seeking the following three types of partners:
・Business and capital alliances
Please feel free to contact us at the following e-mail address:
New York General Group, Inc.
New York General Groupとクリスタルメソッド、汎用人工知能（AGI）の研究開発に関する共同研究・業務提携を開始
「世界平和への多角的アプローチ」ー 弊社取締役副社長、小川が国連気候変動枠組条約締約国会議 （COP28）で新しいビジョンを提示
【New York General Group】人工知能に高度な数学・物理学に基づく「タイムマシンの発明」を行わせることに成功